You can read the financial files from Acro on www.pinksheets.com and you will see that they lost more than 4 mil. $ since 2002 and their sales income is almost nothing. Therefore they are no real competitor for Identa, which I believe is not ready to take off, they already have taken off.
Let's hope for a good end of year and a fantastic 2011 for Identa.
The terminology and claims to effectiveness are startlingly similar to Identa's and like Identa very scant info on the orders. So in a twisted sort of way IDTA and ACRI are like two peas in a pod. Going no where fast! Difference being ACRI does not seem to have recanted on these orders to best of my knowledge. Counter to metbull I think they must be very strong competitors to Identa's line IMO.